{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:21:27Z","timestamp":1788366087912,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Robotic Surg"],"DOI":"10.1007\/s11701-026-03894-5","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:21:38Z","timestamp":1788322898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of positive lymph nodes on robotic radical prostatectomy: medium-term oncological outcomes"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1149-815X","authenticated-orcid":false,"given":"Augusto","family":"Buffa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Banda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9616-5819","authenticated-orcid":false,"given":"Ignacio","family":"Tobia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo F.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8569-2859","authenticated-orcid":false,"given":"Wenceslao","family":"Villamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"3","key":"3894_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/cncr.22034","volume":"107","author":"GP Swanson","year":"2006","unstructured":"Swanson GP, Thompson IM, Basler J (2006) Current status of lymph node-positive prostate cancer: incidence and predictors of outcome. Cancer 107(3):439\u2013450","journal-title":"Cancer"},{"issue":"2","key":"3894_CR2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2011.11.002","volume":"61","author":"F Abdollah","year":"2012","unstructured":"Abdollah F, Gandaglia G, Suardi N, Capitanio U, Salonia A, Nini A, Briganti A (2012) More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer. Eur Urol 61(2):360\u2013368","journal-title":"Eur Urol"},{"issue":"6","key":"3894_CR3","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.juro.2017.12.048","volume":"199","author":"AN Bernstein","year":"2018","unstructured":"Bernstein AN, Shoag JE, Golan R, Halpern JA, Schaeffer EM, Hsu WC, Nguyen PL, Sedrakyan A, Chen RC, Eggener SE, Hu JC (2018) Contemporary incidence and outcomes of prostate cancer lymph node metastases. J Urol 199(6):1510\u20131517","journal-title":"J Urol"},{"issue":"2","key":"3894_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.eururo.2013.11.002","volume":"65","author":"A Heidenreich","year":"2014","unstructured":"Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, van der Joniau S et al (2014) EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 65(2):467\u2013479","journal-title":"Eur Urol"},{"issue":"5","key":"3894_CR5","first-page":"949","volume":"54","author":"O Yossepowitch","year":"2008","unstructured":"Yossepowitch O, Bianco FJ Jr, Eggener SE, Eastham JA, Scher HI, Scardino PT, Fine SW (2008) The natural history of noncastrate metastatic prostate cancer after radical prostatectomy. Eur Urol 54(5):949\u2013956","journal-title":"Eur Urol"},{"key":"3894_CR6","unstructured":"European Association of Urology, EAU-EANM-ESTRO-ESUR-ISUP -SIOG guidelines on prostate cancer. Available at: https:\/\/uroweb.org\/guidelines\/prostate-cancer\/chapter\/introduction (accessed 2026)"},{"issue":"5","key":"3894_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.euo.2020.08.005","volume":"3","author":"G Marra","year":"2020","unstructured":"Marra G, Valerio M, Heidegger I, Tsaur I, Mathieu R, Ceci F et al (2020) Management of patients with node-positive prostate cancer at radical prostatectomy and pelvic lymph node dissection: a systematic review. Eur Urol Oncol 3(5):565\u2013581","journal-title":"Eur Urol Oncol"},{"key":"3894_CR8","doi-asserted-by":"publisher","first-page":"953069","DOI":"10.3389\/fonc.2022.953069","volume":"12","author":"J Hu","year":"2022","unstructured":"Hu J, Yu Y, Liu W, Zhong J, Zhou X, Xi H (2022) The survival benefit of different lymph node yields in radical prostatectomy for pN1M0 prostate cancer patients: implications from a population-based study. Front Oncol 12:953069","journal-title":"Front Oncol"},{"issue":"8\u20139","key":"3894_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.purol.2023.05.001","volume":"33","author":"W Berchiche","year":"2023","unstructured":"Berchiche W, Long Depaquit T, Baboudjian M, Barret \u00c9, Rozet F, Cathelineau X, Bastide C (2023) Mid-term oncologic outcomes of radical prostatectomy in lymph node metastatic prostate cancer patients. Prog Urol 33(8\u20139):437\u2013445","journal-title":"Prog Urol"},{"issue":"5","key":"3894_CR10","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.eururo.2006.08.015","volume":"50","author":"A Briganti","year":"2006","unstructured":"Briganti A, Chun FK, Salonia A, Suardi N, Gallina A, Da Pozzo LF et al (2006) Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 50(5):1006\u20131013","journal-title":"Eur Urol"},{"issue":"6","key":"3894_CR11","first-page":"1279","volume":"100","author":"D Leibovici","year":"2007","unstructured":"Leibovici D, Kordan Y, Pisters LL, Liu HH, Kamat AM, Wood C et al (2007) Contemporary radical retropubic prostatectomy: perioperative outcomes in 430 consecutive patients. BJU Int 100(6):1279\u20131283","journal-title":"BJU Int"},{"issue":"2\u20133","key":"3894_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.euf.2016.02.018","volume":"3","author":"P Mandel","year":"2017","unstructured":"Mandel P, Kriegmair MC, Bogdan K, Boehm K, Bud\u00e4us L, Graefen M et al (2017) Association between lymph node counts and oncological outcomes in lymph node positive prostate cancer. Eur Urol Focus 3(2\u20133):248\u2013255","journal-title":"Eur Urol Focus"},{"issue":"7","key":"3894_CR13","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1111\/cas.15383","volume":"113","author":"M Shiota","year":"2022","unstructured":"Shiota M, Takamatsu D, Kimura T, Tashiro K, Matsui Y, Tomida R et al (2022) Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancer. Cancer Sci 113(7):2386\u20132396","journal-title":"Cancer Sci"},{"issue":"6","key":"3894_CR14","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.eururo.2017.09.027","volume":"73","author":"KA Touijer","year":"2018","unstructured":"Touijer KA, Karnes RJ, Passoni N, Sjoberg DD, Assel M, Fossati N et al (2018) Survival outcomes of men with lymph node-positive prostate cancer after radical prostatectomy: a comparative analysis of different postoperative management strategies. Eur Urol 73(6):890\u2013896","journal-title":"Eur Urol"},{"issue":"1","key":"3894_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2019.01.048","volume":"76","author":"F Preisser","year":"2019","unstructured":"Preisser F, Chun FKH, Pompe RS, Heinze A, Salomon G, Graefen M et al (2019) Persistent prostate-specific antigen after radical prostatectomy and its impact on oncologic outcomes. Eur Urol 76(1):106\u2013114","journal-title":"Eur Urol"},{"issue":"4","key":"3894_CR16","first-page":"543","volume":"116","author":"D Tilki","year":"2015","unstructured":"Tilki D, Mandel P, Schlomm T, Chun FK, Tennstedt P, Pehrke D et al (2015) Lymph node dissection for prostate cancer: implications in the era of robot-assisted and minimally invasive radical prostatectomy. BJU Int 116(4):543\u2013553","journal-title":"BJU Int"},{"issue":"1","key":"3894_CR17","first-page":"e33","volume":"13","author":"R Schiavina","year":"2015","unstructured":"Schiavina R, Manferrari F, Garofalo M, Bianchi L, Vagnoni V, Concetti S et al (2015) Prognostic impact of prostate-specific antigen and nodal status after radical prostatectomy in lymph node-positive prostate cancer patients. Clin Genitourin Cancer 13(1):e33\u2013e38","journal-title":"Clin Genitourin Cancer"}],"container-title":["Journal of Robotic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-03894-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11701-026-03894-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-03894-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:03:52Z","timestamp":1788365032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11701-026-03894-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3894"],"URL":"https:\/\/doi.org\/10.1007\/s11701-026-03894-5","relation":{},"ISSN":["1863-2491"],"issn-type":[{"value":"1863-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"3 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to retrospective nature of this study and the complete anonymization of the patient data, formal approve from the Hospital Ethics Committee was waived, in accordance to local regulations.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Given the retrospective, de-identified nature of the analysis, a waiver of individual informed consent was requested from the Ethics Committee.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable \u2014 this manuscript does not contain any individual person\u2019s identifiable data, images, or videos.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"934"}}